Table 1.
Comparison of Patient Characteristics Between T3 (Overall Adversity Score ≥ 16) and T1+T2 (Overall Adversity Score < 16) Groups
| Total Population (n = 95) | T1+T2 (Overall Adversity Score < 16) (n = 61) | T3 (Overall Adversity Score ≥ 16) (n = 34) | P Value | |
|---|---|---|---|---|
| Age, y | 46 (43–48) | 45 (43–47) | 47 (43–49) | .21 |
| Female, n, % | 52 (54.7) | 32 (42.6) | 20 (58.8) | .55 |
| Race, African-American, n, %a | 53 (56.4) | 26 (42.6) | 27 (81.8) | <.001 |
| Smoking, n, % | 27 (28.4) | 15 (24.6) | 12 (35.3) | .27 |
| Bachelor's degree, n, %b | 28 (31.5) | 23 (39.7) | 5 (16.1) | .02 |
| BDI ≥21 and/or psychiatric medication, n, %a | 30 (31.6) | 13 (22.4) | 17 (63.0) | .003 |
| BMI, kg/m2b | 28.9 (25.9–34.5) | 28.2 (24.4–33.2) | 30.7 (27.3–41.6) | .02 |
| Waist to hip ratio | 0.88 (0.81–0.93) | 0.85 (0.81–0.92) | 0.89 (0.82–0.94) | .21 |
| Waist circumference, cma | 99.3 (88.0–112.5) | 92.8 (86.55–109.3) | 104.65 (93.65–118.3) | .002 |
| Metabolic syndrome, n, % | 25 (26.3) | 14 (23.0) | 11 (32.4) | .32 |
| AHEI | 43.1 (35.1–52.3) | 44.6 (35.9–55.8) | 42.1 (33.7–49.2) | .16 |
| Physical activity, MET h/wk | 11.0 (0–29.3) | 13 (0–31.5) | 9.3 (0–19.4) | .12 |
| Fasting glucose, ng/mL | 90.6 (84.0–96.0) | 90.5 (83.3–94.9) | 90.8 (84.6–98.3) | .43 |
| Fasting insulin, ng/mL | 5.8 (3.2–10.3) | 5.1 (3.2–9.1) | 7.6 (4.0–11.9) | .22 |
| Leptin, ng/mLa | 22.8 (6.9–37.0) | 14.2 (3.9–34.1) | 33.9 (20.1–45.6) | .001 |
| Adiponectin, ng/mLb | 7.5 (4.8–11.9) | 9.1 (5.4–13.0) | 6.6 (3.8–8.6) | .03 |
| Irisin, ng/mLb | 171.8 (142.5–214.2) | 161.2 (137.8–190.4) | 203.7 (163.9–220.5) | .02 |
| CRP, mg/dLb | 1.6 (0.6–3.7) | 1.2 (0.5–3.0) | 2.2 (1.0–4.5) | .02 |
Data are presented in number (percentage) or median (interquartile range); value of P < .05 is in bold.
a
P < .01, Wilcoxon rank-sum test for continuous variables, χ2 test for categorical variables.
b
P < .05, Wilcoxon rank-sum test for continuous variables, χ2 test for categorical variables.